Integrated Filing — IndAS



General information about company

Scrip Code 531599
NSE Symbol FDC
MSEI Symbol NOTLISTED
ISIN INE258B01022
Name of company FDC LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 05-08-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-07-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Single segment
Description of single segment PHARMACEAUTICAL
Start date and time of board meeting 05-08-2026   12:30:00
End date and time of board meeting 05-08-2026   14:30:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 65,510.00 65,510.00
Other income 4,734.00 4,734.00
Total income 70,244.00 70,244.00
2 Expenses
(a) Cost of materials consumed 14,116.00 14,116.00
(b) Purchases of stock-in-trade 2,146.00 2,146.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 4,631.00 4,631.00
(d) Employee benefit expense 13,373.00 13,373.00
(e) Finance costs 82.00 82.00
(f) Depreciation, depletion and amortisation expense 1,509.00 1,509.00
(f) Other Expenses
1 Other Expenses 16,960.00 16,960.00
Total other expenses 16,960.00 16,960.00
Total expenses 52,817.00 52,817.00
3 Total profit before exceptional items and tax 17,427.00 17,427.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 17,427.00 17,427.00
6 Tax expense
7 Current tax 3,970.00 3,970.00
8 Deferred tax 255.00 255.00
9 Total tax expenses 4,225.00 4,225.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 13,202.00 13,202.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 13,202.00 13,202.00
17 Other comprehensive income net of taxes 15.00 15.00
18 Total Comprehensive Income for the period 13,217.00 13,217.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,628.00 1,628.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 8.11 8.11
Diluted earnings (loss) per share from continuing operations 8.11 8.11
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 8.11 8.11
Diluted earnings (loss) per share from continuing and discontinued operations 8.11 8.11
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above unaudited standalone financial results which are published in accordance with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) for the quarter ended June 30, 2026, have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 5, 2026. The Statutory Auditors have carried out a limited review of the above results and have expressed an unmodified review conclusion. 2. During the previous year, the Company recognised a fair value loss of Rs. 1,330 lakhs under Other expenses in the quarter ended March 31, 2026 in accordance with Ind AS 109 – ‘Financial Instruments’. However, for the period ended March 31, 2026, a net fair value gain of Rs. 1,179 lakhs was recognised under Other income. Due to this treatment, the quarterly numbers may not be directly additive to the year-to-date (YTD) numbers, as fair value changes are recognised based on market conditions prevailing at different reporting dates. 3. During the previous year, the Company recognised an incremental employee benefit obligation of Rs. 2,079 lakhs based on an actuarial valuation in accordance with Ind AS 19 – ‘Employee Benefits‘. The impact was disclosed as an exceptional item in the financial statements for the year ended March 31, 2026, considering its non-recurring nature arising from a regulatory change. The Company continues to monitor further notifications and clarifications issued by the Government and will account for any consequential impact, if required, in the period of such developments. 4. During the previous year, the Company had paid an interim dividend of Rs. 5 per equity share of face value Rs. 1 each for the financial year 2025-26, as approved by the Board of Directors of the Company at their meeting held on February 5, 2026. 5. The Company has only one segment of activity namely “Pharmaceuticals”. 6. Figures for the quarter ended March 31, 2026 are the balancing figures between audited figures in respect of the full financial year ended as on March 31, 2026 and the published year-to-date figures up to end of the third quarter ended as on December 31, 2025 of the relevant financial year. Also, the figures upto the end of third quarter had only been reviewed and not subjected to audit. 7. The above results are also available on the website of the Company i.e. www.fdcindia.com and on the website of the Stock Exchanges i.e. www.nseindia.com and www.bseindia.com.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026 01-04-2026
Date of end of reporting period 30-06-2026 30-06-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026 01-04-2026
B Date of end of reporting period 30-06-2026 30-06-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified subsequently to profit or loss 17.00 17.00
Total Amount of items that will not be reclassified to profit and loss 17.00
2 Income tax relating to items that will not be reclassified to profit or loss 2.00 2.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 15.00 15.00